Evidence map›Paper›PMID 40235616›Full record

ReviewFocus (American Psychiatric Publishing)2025

Symptom Severity and Treatment Needs Among Racial Groups Seeking Treatment at a Mood Outcomes Program.

Jorge A Sanchez-Ruiz, Jason Straub, Peter P Zandi, Olusola Ajilore, Brandon J Coombes, Stephen M Strakowski, Mark A Frye, Monica J Taylor-Desir

Abstract readReview
In one paragraph

Review in Focus (American Psychiatric Publishing), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jorge A Sanchez-RuizDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).ORCID https://orcid.org/0000-0003-4282-7359
Jason StraubDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).
Peter P ZandiDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).
Olusola AjiloreDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).ORCID https://orcid.org/0000-0003-0737-0437
Brandon J CoombesDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).ORCID https://orcid.org/0000-0003-4322-5923
Stephen M StrakowskiDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).
Mark A FryeDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).
Monica J Taylor-DesirDepartment of Psychiatry and Psychology (Sanchez-Ruiz, Frye, Taylor-Desir) and Department of Quantitative Health Sciences (Coombes), Mayo Clinic, Rochester, Minnesota; Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore (Straub, Zandi); Department of Psychiatry, University of Illinois at Chicago (Ajilore); Department of Psychiatry, Dell Medical School, The University of Texas at Austin, Austin (Strakowski).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mood disorders are highly prevalent. Despite increased rates of treatment provision, treatment gaps are sustained by inadequate targeting of interventions and little emphasis on prevention. Here, the authors present an overview and analysis of the National Network of Depression Centers (NNDC) Mood Outcomes Program, which is both a measurement-based care program, with a standardized set of mood "vital signs" assessed as part of routine clinical care, and a learning health system. The authors analyzed all data collected since the program's inception in 2015 to assess whether baseline symptom severity, prior suicidal ideation or attempts, length of care, and longitudinal symptom severity differed across sociodemographic groups. The results show important treatment needs that are not being fulfilled. Most notably, the groups with the greatest symptom severity were not the groups with the most visits. Efforts to address systemic barriers that prevent access to mental health care are required. Given that the NNDC Mood Outcomes Program is integrated with clinical care, academic programs, and research at each site, the authors anticipate that the program is well suited to support efforts to dismantle systemic barriers to care.

Indexed as

Bipolar and Related DisordersHealth Services Needs and DemandMajor Depressive DisorderRace/Racial DisparitiesRegistriesSuicidal Ideation

Identifiers

PMID40235616
PMCPMC11995912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.